Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000368.5(TSC1):c.2299C>T(p.Gln767*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-132902697-G-A is Pathogenic according to our data. Variant chr9-132902697-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 48936.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr9-132902697-G-A is described in Lovd as [Pathogenic].
Review Status: criteria provided, single submitter
Collection Method: clinical testing
PM2_Supporting+PVS1+PS4_Supporting -
TSC1-related disorder Pathogenic:1
Dec 04, 2023
PreventionGenetics, part of Exact Sciences
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing
The TSC1 c.2299C>T variant is predicted to result in premature protein termination (p.Gln767*). This variant was reported in an individual with tuberous sclerosis (Dabora et al. 2001. PubMed ID: 11112665). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in TSC1 are expected to be pathogenic. This variant is interpreted as pathogenic. -